The effect of P-CAB in patients with functional dyspepsia; A prospective, single-arm, multicenter study

Not Applicable

• Conditions: Diseases of the digestive system

• Registration Number: KCT0005600
• Lead Sponsor: Yonsei University Health System, Gangnam Severance Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 December 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 187

Inclusion Criteria

? = 19 years
? Patients with functional dyspepsia that meet Roman criteria IV

Exclusion Criteria

? In case of esophagus stenosis, ulcer stenosis, esophageal varix, Barrett's esophagus, active peptic ulcer, GI bleeding and Eosinophilic esophagitis on upper gastrointestinal endoscopy
? Patients who have undergone surgery on the esophagus, stomach, and duodenum
? Patients with a history of malignant tumors within the last 5 years
? Patients with clinically significant disorders in liver, kidney, cardiovascular system, respiratory system, endocrine system, and central nervous system
? Those who have a history of hypersensitivity reactions to components of tegoprazan or benzimidazoles
? Those who are administering atazanavir, nelpinavir, or drug containing rilpivirine
? pregnant or lactating women
? Any other condition likely in the judgment of the investigator that make the participants unable to complete, or is unsuitable for the study.

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall Responder rate

Secondary Outcome Measures

Name	Time	Method
Overall improvement in dyspepsia symptoms